Stocks and Investing
Stocks and Investing
Mon, November 15, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jailendra Singh Maintained (CAH) at Hold with Decreased Target to $50 on, Nov 15th, 2021
Jailendra Singh of Credit Suisse, Maintained "Cardinal Health, Inc." (CAH) at Hold with Decreased Target from $53 to $50 on, Nov 15th, 2021.
Jailendra has made no other calls on CAH in the last 4 months.
There are 3 other peers that have a rating on CAH. Out of the 3 peers that are also analyzing CAH, 1 agrees with Jailendra's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- George Hill of "Deutsche Bank" Downgraded from Strong Buy to Hold and Decreased Target to $51 on, Friday, August 6th, 2021
These are the ratings of the 2 analyists that currently disagree with Jailendra
- Steve Valiquette of "Barclays" Maintained at Buy with Decreased Target to $65 on, Wednesday, November 10th, 2021
- Michael Cherny of "B of A Securities" Downgraded from Strong Buy to Sell and Decreased Target to $56 on, Thursday, August 5th, 2021
Contributing Sources